Page 109 - 《中国药房》2024年21期
P. 109

phrotic syndrome:experience of a Portuguese tertiary cen‐  syndrome:its  effects  on  disease  progression  and  growth
              ter[J]. J Bras Nefrol,2023,45(3):326-334.           [J]. Front Pediatr,2019,7:313.
          [35]  TELLIER S,BROCHARD K,GARNIER A,et al. Long-  [45]  任静,唐文娟,邵珍珍,等. 68例单次利妥昔单抗治疗儿
              term outcome of children treated with rituximab for idio‐  童原发性肾病综合征激素依赖的护理[J]. 全科护理,
              pathic  nephrotic  syndrome[J].  Pediatr  Nephrol,2013,28  2019,17(25):3149-3151.
              (6):911-918.                                        REN J,TANG W J,SHAO Z Z,et al. Nursing care of 68
          [36]  WEBB H,JAUREGUIBERRY G,DUFEK S,et al. Cyclo‐      cases of hormone dependence in children with primary ne‐
              phosphamide  and  rituximab  in  frequently  relapsing/  phrotic  syndrome  treated  with  single  rituximab[J].  Chin
              steroid-dependent nephrotic syndrome[J]. Pediatr Nephrol,  Gen Pract Nurs,2019,17(25):3149-3151.
              2016,31(4):589-594.                            [46]  张涛,沈茜,徐虹,等. 利妥昔单抗治疗儿童原发性难治
          [37]  NIU X L,HAO S,WANG P,et al. Single dose of rituxi-   性肾病综合征疗效及其影响因素的自身前后对照研究
              mab  in  children  with  steroid-dependent  minimal  change   [J]. 中国循证儿科杂志,2018,13(3):161-165.
              nephrotic syndrome[J]. Biomed Rep,2016,5(2):237-242.  ZHANG T,SHEN Q,XU H,et al. The effect and multiple-
          [38]  都娟,黄建萍,王硕,等. 利妥昔单抗在小儿频复发肾病                        factor analysis of rituximab treatment in children with pri‐
              综合征中的应用[J]. 中华实用儿科临床杂志,2014,29                      mary refractory nephrotic syndrome[J]. Chin J Evid Based
              (9):659-662.                                        Pediatr,2018,13(3):161-165.
              DU J,HUANG J P,WANG S,et al. Rituximab in treat‐  [47]  WANG C S,GREENBAUM L A. Nephrotic syndrome[J].
              ment  of  children  with  frequently  relapsed  nephrotic  syn‐  Pediatr Clin N Am,2019,66(1):73-85.
              drome[J]. Chin J Appl Clin Pediatr,2014,29(9):659-662.  [48]  DELBET J D,LECLERC G,ULINSKI T. Idiopathic ne‐
          [39]  方香,高春林,夏正坤,等. 利妥昔单抗治疗儿童频繁复                        phrotic syndrome and rituximab:may we predict circula-
              发型肾病综合征的远期观察[J]. 中华实用儿科临床杂                          ting B lymphocytes recovery?[J]. Pediatr Nephrol,2019,
              志,2019,34(5):352-354.                               34(3):529-532.
              FANG X,GAO C L,XIA Z K,et al. Long-term observa‐  [49]  JELLOULI M,CHARFI R,MAALEJ B,et al. Rituximab
              tion of rituximab therapy for children with frequently re‐  in the management of pediatric steroid-resistant nephrotic
              lapsing nephrotic syndrome[J]. Chin J Appl Clin Pediatr,  syndrome:a  systematic  review[J].  J  Pediatr,2018,197:
              2019,34(5):352-354.                                 191-197.e1.
          [40]  王道静,王筱雯,丁娟娟,等. 利妥昔单抗在儿童难治性                   [50]  XUE  C,YANG  B,XU  J,et  al.  Efficacy  and  safety  of
              肾病综合征中的疗效评估[J]. 中华实用儿科临床杂志,                         rituximab in adult frequent-relapsing or steroid-dependent
              2022,37(19):1473-1477.                              minimal change disease or focal segmental glomeruloscle‐
              WANG D J,WANG X W,DING J J,et al. Evaluation of     rosis:a systematic review and meta-analysis[J]. Clin Kid‐
              the therapeutic effect of rituximab in children with refrac‐  ney J,2021,14(4):1042-1054.
              tory  nephrotic  syndrome  [J]  Chin  J Appl  Clinic  Pediatr,  [51]  HOGAN J,DOSSIER C,KWON T,et al. Effect of diffe-
              2022,37 (19):1473-1477.                             rent rituximab regimens on B cell depletion and time to re‐
          [41]  王汝琼,林道炯,吴守业,等. 利妥昔单抗对激素依赖型                        lapse  in  children  with  steroid-dependent  nephrotic  syn‐
              肾病综合征患儿T淋巴细胞亚群和尿CD80水平的影响                           drome[J]. Pediatr Nephrol,2019,34(2):253-259.
              [J]. 东南大学学报(医学版),2021,40(5):612-617.           [52]  MAXTED A P,DALRYMPLE R A,CHISHOLM D,et al.
              WANG R Q,LIN D J,WU S Y,et al. Effects of rituximab   Low-dose rituximab is no less effective for nephrotic syn‐
              on T lymphocyte subsets and urinary CD80 levels in chil‐  drome  measured  by  12-month  outcome[J].  Pediatr
              dren  with  steroid-dependent  nephrotic  syndrome[J].  J   Nephrol,2019,34(5):855-863.
              Southeast Univ(Med Sci Ed),2021,40(5):612-617.  [53]  KEMPER  M  J,ALTROGGE  H,GANSCHOW  R,et  al.
          [42]  TAŞDEMIR  M,CANPOLAT  N,YILDIZ  N,et  al.  Ritu-   Serum  levels  of  immunoglobulins  and  IgG  subclasses  in
              ximab  treatment  for  difficult-to-treat  nephrotic  syndrome   steroid sensitive nephrotic syndrome[J]. Pediatr Nephrol,
              in  children:a  multicenter,retrospective  study[J].  Turk  J   2002,17(6):413-417.
              Med Sci,2021,51(4):1781-1790.                  [54]  KAMEI  K,TAKAHASHI  M,FUYAMA  M,et  al.
          [43]  HOSEINI R,SABZIAN K,OTUKESH H,et al. Efficacy     Rituximab-associated agranulocytosis in children with re‐
              and  safety  of  rituximab  in  children  with  steroid-  and   fractory idiopathic nephrotic syndrome:case series and re‐
              cyclosporine-resistant  and  steroid-  and  cyclosporine-  view  of  literature[J].  Nephrol  Dial  Transplant,2015,30
              dependent  nephrotic  syndrome[J].  Iran  J  Kidney  Dis,  (1):91-96.
              2018,12(1):27-32.                                             (收稿日期:2024-04-16  修回日期:2024-09-27)
          [44]  TOPALOĞLU  R,GÜLHAN  B,ÇELEGEN  K,et  al.                                         (编辑:舒安琴)
              Rituximab  for  children  with  difficult-to-treat  nephrotic


          中国药房  2024年第35卷第21期                                              China Pharmacy  2024 Vol. 35  No. 21    · 2675 ·
   104   105   106   107   108   109   110   111   112   113   114